Skip to main content
. 2021 Dec 7;41(12):BSR20211640. doi: 10.1042/BSR20211640

Figure 2. Heatmaps present different expression levels of FRGs among distinct glioma subgroups.

Figure 2

(A) Differential expression levels of 28 FRGs between WHO grade II LGGs and grade III LGGs. (B) Differential expression levels of 28 FRGs among WHO grade II, III, and IV gliomas. (C) Differential expression levels of 28 FRGs between IDH-wildtype and IDH-mutant LGGs. (D) Differential expression levels of 28 FRGs between IDH-wildtype and IDH-mutant GBMs. (E) Differential expression levels of 28 FRGs between 1p/19q co-deletion and 1p/19q non-codeletion IDH-mutant LGGs. *P<0.05, **P<0.01, ***P<0.001.